Galsulfase

recombinant human N-acetylgalactosamine 4-sulfatase (rhASB) · BioMarin Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Galsulfase, covering 2009-08-17 to 2009-08-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI [Phase 3]